Company Filing History:
Years Active: 2019-2025
Title: The Innovative Contributions of Anthony Manning
Introduction
Anthony Manning is a prominent inventor based in Cambridge, MA, known for his significant contributions to the field of neurodegeneration treatment. With a total of six patents to his name, Manning has made strides in developing methods that address critical health issues, particularly in neurodegenerative diseases.
Latest Patents
Manning's latest patents include groundbreaking inventions such as "Methods for the treatment of neurodegeneration." This invention highlights the discovery that Fc-containing polypeptides, which include branched glycans and are sialylated, can be effective in treating neurodegenerative diseases like Alzheimer's Disease. The patent outlines methods for administering these compositions and for evaluating and producing such polypeptides. Another notable patent is "FcRn antibodies and methods of use thereof," which features antibodies with high binding affinity to the human neonatal Fc receptor (FcRn). These antibodies are designed to promote the clearance of autoantibodies and block immune responses, making them valuable in treating autoimmune diseases.
Career Highlights
Anthony Manning is currently associated with Momenta Pharmaceuticals, Inc., where he continues to innovate and contribute to the field of biotechnology. His work focuses on developing therapeutic solutions that can significantly improve patient outcomes in neurodegenerative and immunological diseases.
Collaborations
Manning collaborates with esteemed colleagues such as Leona E Ling and Marilyn Kehry, who contribute to the research and development efforts at Momenta Pharmaceuticals.
Conclusion
Anthony Manning's innovative work in the treatment of neurodegeneration and immunological diseases showcases his dedication to advancing medical science. His patents reflect a commitment to finding effective solutions for complex health challenges.